Диссертация (1140852), страница 29
Текст из файла (страница 29)
736-755.• Antoniou, K.M. Quality of life in patients with active sarcoidosis in Greece /K. M. Antoniou, N. Tzanakis, A. Tzouvelekis et al. //European Journal ofInternal Medicine. – 2006. - №17. – P. 421-426.• Ayuso-Mateos, J.L. Depressive disorders in Europe: prevalence figures fromthe ODIN study / J. L. Ayuso-Mateos, J. L.Vazques-Barquero, C. Dowrick //The British Journal of Psychiatry. – 2001. -№179. – P. 308-316.• Baldwin, D. Evidence-based guidelines for the pharmacological treatment ofanxiety disorders: recommendations from the British Association forPsychopharmacology / D.
Baldwin, I Anderson, D. Nutt et al. // JPsychopharmacol. – 2006. - № 19(6). – P. 567-596.• Baugham, R. Clinical characteristics of patients in a case control study ofsarcoidosis / R. Baugham, A. Teirstein, M. Judson // Am J Respir Crit CareMed. – 2001. -№164(10). – P. 1885-9.• Baumeister, H. Bronchial asthma and mental disorders - a systematic reviewof empirical studies / H. Baumeister, K. Korinthenberg, J.
Bengel et al. //Psychother Psychosom Med Psychol. – 2005. - №55(5). – P. 247-55.•Beste, C. Effects of fatigue on cognitive control in neurosarcoidosis / C.Beste, J. Kneiphof, D. Woitalla // Eur Neuropsychopharmacol. 2015. №25(4).- P. 522-30.• Borson, S. Examining the link between sarcoidosis and depression / S.Borson, C. Randall // American Journal of Respiratory and Critical CareMedicine. -2001. -№163(2). – P. 306-308.172• Bosse-Henck, A. Subjective sleep quality in sarcoidosis / A.
Bosse-Henck //Sleep Med. – 2015. - №16(5). – P. 570-6.• Briner, V. Neurosarcoidosis / V. Briner, A. Muller, J. Gebbers // SchweizMed Wochenschr. – 1998. - №128(21). – P. 799-810.•Burt, D. Depression and memory impairment: a metaanalysis of theassociation, its pattern, and specificity / D. Burt, M. Zembar, G. Niederehe //Psychol. Bull. -1995.
- №117. – P. 285-305.• Chang, B. Depression in sarcoidosis / B. Chang, J. Steimel, D. Moller et al.// American Journal of Respiratory and Critical Care Medicine. 2001. №163(2). – P. 329-334. http://dx.doi.org/ HYPERLINK"http://dx.doi.org/10.1164/ajrccm.163.2.2004177" HYPERLINK"http://dx.doi.org/10.1164/ajrccm.163.2.2004177" HYPERLINK"http://dx.doi.org/10.1164/ajrccm.163.2.2004177"10.1164 HYPERLINK"http://dx.doi.org/10.1164/ajrccm.163.2.2004177" HYPERLINK"http://dx.doi.org/10.1164/ajrccm.163.2.2004177" HYPERLINK"http://dx.doi.org/10.1164/ajrccm.163.2.2004177"/ajrccm. HYPERLINK"http://dx.doi.org/10.1164/ajrccm.163.2.2004177" HYPERLINK"http://dx.doi.org/10.1164/ajrccm.163.2.2004177" HYPERLINK"http://dx.doi.org/10.1164/ajrccm.163.2.2004177"163.2.2004177• Cox, C.
Health-related quality of life of persons with sarcoidosis / C. Cox, J.Donohue, C. Brown // Chest. – 2004. - №125. – P. 997–1004.http://dx.doi.org/ HYPERLINK "http://dx.doi.org/10.1378/chest.125.3.997"HYPERLINK "http://dx.doi.org/10.1378/chest.125.3.997" HYPERLINK"http://dx.doi.org/10.1378/chest.125.3.997"10.1378 HYPERLINK"http://dx.doi.org/10.1378/chest.125.3.997" HYPERLINK"http://dx.doi.org/10.1378/chest.125.3.997" HYPERLINK"http://dx.doi.org/10.1378/chest.125.3.997"/chest. HYPERLINK173"http://dx.doi.org/10.1378/chest.125.3.997" HYPERLINK"http://dx.doi.org/10.1378/chest.125.3.997" HYPERLINK"http://dx.doi.org/10.1378/chest.125.3.997"125.3.997• De Boer, S.
The relationships among dyspnoea, health-related quality of lifeand psychological factors in sarcoidosis / S. De Boer, J. Kolbe, M. Wilsner //Respirology. – 2014. - №19(7). – P. 1019-24.• De Vries, J. Fatigue, quality of life, and health status in sarcoidosis / J. DeVries, R. Wirnsberger // Eur Respir Mon. – 2005. - №10. – P. 92–104.http://dx.doi.org/ HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007" HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007" HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007"10.1183 HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007" HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007" HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007"/ HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007" HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007" HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007"1025448 HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007" HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007" HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007"x.
HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007" HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007" HYPERLINK"http://dx.doi.org/10.1183/1025448x.00032007"00032007• De Vries, J. Quality of life and health status in sarcoidosis: a review / J. DeVries, M. Drent // Semin Respir Crit Care Med.
– 2007. - №28(1). – P. 1217.174• De Vries, J. Quality of life in sarcoidosis: assessment and management / J.De Vries, E. Lower, M. Drent // Semin Respir Crit Care Med. – 2010. №31(4). – P. 485-93.• Dennolet, J. Personality and Risk of Cancer in. Men with Coronary HeartDisease / J. Dennolet // Psychological Medicine. – 1998. - №28(4). – P.991-5.• Deshields, T. Resilience in adults with cancer: development of a conceptualmodel / T.
Deshields, M Heiland, A. Kracen et al. // Psychooncology. –2016. – № 25(1). – P. 11-18.• Doran С.M. The Hypomania Handbook: The Challenge of Elevated Mood /C. M. Doran. - New-York: LWW, 2008. -311 p.• Drent, M. Consequences of Sarcoidosis / M. Drent, B. Stookappe, A.Hoitma // Clin Chest Med. – 2015. - №36. – P.
727–737.• Drent, M. Fatigue associated with obstructive sleep apnea in a patient withsarcoidosis / M. Drent, J. Verbraecken, C. van der Grinten // Respiration.2000. -№67(3). – P. 337-40.• Drent, M. Quality of life and depressive symptoms in patients suffering fromsarcoidosis / M. Drent, R. Wirnsberger, M. Bretler et al. // Sarcoidosis, Vasc.and diffuse lung dis. – 1998. - №15. – P. 59-66.• Drent, M. Sarcoidosis-associated fatigue / M. Drent, E. Lower, J. De Vries //Eur Respir J. - 2012.
- №40. – P. 255-263.• Drent, M. Sarcoidosis: benefits of a multidisciplinary approach / M. Drent //European J. Int.med. – 2003. - №14. – P. 217-220.175• Duwe, B. Misdiagnosis of schizophrenia in a patient with psychoticsymptoms / B. Duwe, B. Turetsky // Neuropsychiatry Neuropsychol BehavNeurol. – 2002. - №15(4). – P. 252-60.• Elfferich, M. Everyday cognitive failure in sarcoidosis: the prevalence andthe effect of anti-TNF-alpha treatment / M.
Elferich, P. Melmans, R. Pondset al. // Respiration. - 2010. - №80(3). – P. 212-9.• Elfferich, M. Type D or “distressed” personality in sarcoidosis andidiopathic pulmonary fibrosis / M. Elfferich, J. De Vries, M. Drent et al. //Sarcoidosis vasc.diffuse lung dis. – 2011.
- №28. – P. 65-71.• Erdal, B. Unexpectedly high prevalence of sarcoidosis in a representativeU.S. Metropolitan population / B. Erdal, B. Clymer, V. Yildiz et al. // Resp.med. 2012. - №106(6). – P. 893-899.• Escande, M. Reactions and psychic disorders in Besnier —BoeckSchaumann disease: Clinical and psychological approach; application ofascale of aggressive behavior to the mental profile / M. Escnde, J. Gardes, L.Gayral // Ann. Med. Psychol. – 1980.
- №138(7). – P. 813-828.• Ferlinz, R. The etiologic association and treatment of atypical febrilepulmonary diseases in practice / R. Ferlinz // Med Welt. – 1976. - №27(17).– P. 786-95.• Fleischer, M. Factors associated with fatigue in sarcoidosis / M. Fleischer,A. Hinz, E. Brahler et al. // Respiratory care. - 2014.
- №59(7). – P. 10861094.• Foreman, M. Hospitalization for patients with sarcoidosis: 1979-2000 / M.Foreman, D. Mannino, L. Kamugisha et al. // Sarcoidosis Vasc Diffuse LungDis. 2006. - №23(2). – P. 124-9.176• Gerke, A. Increased hospitalizations among sarcoidosis patients from 1998to 2008: a population-based cohort study / A.
Gerke, M. Yang, F. Tang et al.// BMC Pulmonary medicine. – 2012. - №12. – P. 19-23.• Gerke, A. Morbidity and mortality in sarcoidosis / A. Gerke //Curr.Opin.Pulm.Med. – 2014. - №20(5). – p. 472-480.• Gideon, N. Sarcoidosis mortality in the United States 1979-1991: an analysisof multiple-cause mortality data / N. Gideon, D. Mannino // Am J Med. 1996. - №100(4). – P. 423-7.• Glatzel, J. Leibgefuhlsstorungen bei endogenen Psychosen : Schizophrenieund Zyklothymie. Ergebnisse und Probleme / J.
Glatzel; ed. G. Huber. –Stuttgart: Thieme, 1969. – S. 163-176.• Goracci, A. Quality of life, anxiety and depression in Sarcoidosis / A.Goracci, A. Fagiolini, M. Martinucci et al. // Gen.Hospital Psychiatry. 2008.- №30. – P. 441-445.• Guy, W, ECDEU Assessment Manual for Psychopharmacology / W. Guy. –Rockville, 1976. – 234 p.• Hinz, A. Anxiety and depression in sarcoidosis: the influence of age, gender,affected organs, concomitant diseases and dyspnea / A.
Hinz, E. Brahler, R.Mode et al. // Sarcoidosis Vasc Diffuse Lung Dis. – 2012. - №29(2). – P.139-46.• Holas, P. Anxiety, its relation to symptoms severity and anxiety sensitivityin sarcoidosis / P. Holas, I. Krejtz, T. Urbankowski et al. // J.SarcoidosisVasc Diffuse Lung Dis. - 2013. - №30(4). – P. 282-8.177• Hosoda, Y. Epidemiology of sarcoidosis: New frontiers to explore / Y.Hosoda, S.
Sasagawa, N. Yasuda // Curr Opin Pulm Med. – 2002. - №8. –P. 424-428.•Huber, G. Die coenesthetiche Schizophrenie / G. Huber // Fortchr. Neuroe,Psychiatr. – 1957. – No 9. – S. 491-521.• Jastrzebski, D. Fatigue in sarcoidosis and exercise tolerance, dyspnea, andquality of life / D. Jastrzebski, D. Ziora, M. Lubecki // Adv Exp Med Biol. 2015.
-№833. – P. 31-6.• Jaswa, A. Differential Inflammatory MicroRNA and Cytokine Expression inPulmonary Sarcoidosis / A. Jaswa, L. Kasper, V. Bak et al. //Arch.Immunol.Ther.Exp. – 2015. - №63. – P. 139-146.• John, S. Schizophrenia vs. neurosarcoidosis in a young male / S. John, F.Ovsiew // Psychosomatics. -1996. - №37(2).
– P.166-8.• Johnstone, E. The occurrence of organic disease of possible or probableaetiological significance in a population of 268 cases of first episodeschizophrenia / E. Johnstone, J. Macmillan, T. Crow // Psychol Med. 1987. №17(2). – P. 371-9.• Jonker, K. Treatment of patients with the chronic–fatigue syndrome / K.Jonker, A. M. van Hemert // Nederlands tijdschrift voor geneeskunde. –2006. - V.150(38). – S.
2067–2078.• Judson, M. The Clinical Features of Sarcoidosis: A Comprehensive Review /M. Judson // Clin Rev Allergy Immunol. – 2014. - №49(1). – P. 63-78.• Kapfhammer, H. Somatic symptoms in depression / H. Kapfhammer //Dialogues Clin Neurosci. – 2006. - №8(2). – P. 227–239.• Kessler, R. Epidemiology of women and depression / R. Kessler // Journalof Affective Disorders.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
